InvitroCue Ltd


InvitroCue ASX:IVQInvitroCue Ltd (ASX:IVQ) is a leading healthcare bio-analytic solutions provider including in vitro cell-based testing technologies and image analytics software for use in digital pathology. Invitrocue has developed a unique 3D cell-based scaffolding technology that mimics human organ samples for using in the field of infectious diseases. In 2016, the company expanded its work in liver disease to the field of oncology. Invitrocue's Onco-PDO™ technology enables patient-derived cancer cells (organoids) to be cultured in laboratories for testing against a panel of drugs to support clinical decision making for individual patients (personalised medicine).

Invitrocue's technology originated in Singapore's Agency for Science, Technology and Research (A*STAR). Invitrocue has been developed and validated in partnerships with leading biopharmaceutical companies and scientific collaborators.

Invitrocue is listed on the Australian Securities Exchange under the ticker IVQ.



InvitroCue Ltd (ASX:IVQ) Signs Agreement with London School of Hygiene & Tropical Medicine

🕔3/9/2016 11:27:06 AM 3858

The Directors of InvitroCue Limited (ASX:IVQ) are pleased to announce their recently signed Agreement to collaborate with the highly regarded London School of Hygiene & Tropical Medicine.

Read Full Article


  • This Page Viewed: (Last 7 Days: 1) (Last 30 Days: 3) (Since Published: 1842) 

Company Data

    Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Biotechnology 
  • Homepage

Social Media